Neurofibromatosis tipo 2的临床试验
总计11411个结果
-
Sunshine Guojian Pharmaceutical (Shanghai) Co.,...尚未招聘
-
Massachusetts General HospitalJohns Hopkins University招聘中
-
Children's Hospital Medical Center, Cincinnati主动,不招人
-
The University of Texas Health Science Center,...Texas Neurofibromatosis Foundation完全的
-
Bnai Zion Medical Center未知
-
Universitaire Ziekenhuizen KU Leuven未知
-
Sarcoma Alliance for Research through CollaborationNational Cancer Institute (NCI)完全的
-
Virginia Commonwealth University完全的
-
University of Wisconsin, MilwaukeeNF Midwest主动,不招人
-
University of Wisconsin, MilwaukeeNF Midwest; NF Northeast招聘中
-
NFlection Therapeutics, Inc.完全的
-
Joergen SerupSahlgrenska University Hospital, Sweden主动,不招人
-
Yale UniversityThe Hospital for Sick Children; United States Department of Defense; Connecticut Children's Medical...完全的
-
NFlection Therapeutics, Inc.完全的
-
Kent Robertson完全的
-
Pediatric Brain Tumor ConsortiumNational Cancer Institute (NCI); American Lebanese Syrian Associated Charities (ALSAC)招聘中具有 BRAF 畸变的脑低级别胶质瘤 (LGG) | 具有 BRAF 畸变的大脑高级别胶质瘤 (HGG) | 1 型神经纤维瘤病脑低级别胶质瘤美国
-
Memorial Sloan Kettering Cancer CenterPhenogen Sciences招聘中
-
Jiangsu HengRui Medicine Co., Ltd.完全的
-
National Cancer Institute (NCI)招聘中
-
Vanderbilt UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)招聘中
-
Vanderbilt UniversityNational Institute of Neurological Disorders and Stroke (NINDS)完全的
-
Washington University School of Medicine完全的
-
University Hospital, Strasbourg, France完全的
-
National Cancer Institute (NCI)招聘中
-
National Cancer Institute (NCI)完全的
-
Shenzhen Geno-Immune Medical InstituteShenzhen Children's Hospital; Shenzhen Hospital of Southern Medical University未知
-
Daewoong Pharmaceutical Co. LTD.完全的